Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.32 |
| ▸ | CA2 | P00918 | 4/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4587557 | 0.80 | CA1 (0.36) | CA1CA2NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL2191452 | 0.78 | CA1 (0.35) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL3812152 | 0.72 | NOS3 (0.39) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL14509193 | 0.71 | ALOX15 (0.33) | CA1CA2 | |
| SCHEMBL19152428 | 0.70 | CA1 (0.42) | CA1CA2NOS3NOS1NOS2 | |
| Water SCHEMBL21810558 | 0.70 | NOS3 (0.38) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL13897077 | 0.70 | NOS3 (0.38) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL3056410 | 0.70 | CA1 (0.41) | CA1CA2NOS3NOS1NOS2 | |
| SCHEMBL22930932 | 0.69 | CA12 (0.35) | CA1CA2 | |
| SCHEMBL5568466 | 0.69 | NOS3 (0.35) | CA1CA2NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172306-A1 | CREATINE ESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS | VENNERSTROM JONATHAN L | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172306-A1 | CREATINE ESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS | CKMT1A; CKMT1B, CPT1B, PYGM | CA1 3741/4885CA2 3569/4885NOS3 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.